BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 14587653)

  • 1. Cyclic GMP production by ANP, BNP, and NO during worsening and improvement of chronic heart failure.
    Takahashi M; Takeda S; Kurokawa S; Kubo T; Fukuda N; Izumi T
    Jpn Heart J; 2003 Sep; 44(5):713-24. PubMed ID: 14587653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure].
    Kobusiak-Prokopowicz M; Swidnicka-Szuszkowska B; Mysiak A
    Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma concentrations of atrial and brain natriuretic peptides and cyclic guanosine monophosphate in response to dobutamine infusion in patients with surgically repaired tetralogy of fallot.
    Hayabuchi Y; Matsuoka S; Kuroda Y
    Pediatr Cardiol; 1999; 20(5):343-50. PubMed ID: 10441688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of natriuretic peptides and cyclic GMP in hemodialysis patients with coronary artery disease.
    Osajima A; Okazaki M; Kato H; Anai H; Tsuda Y; Segawa K; Tanaka H; Tamura M; Takasugi M; Nakashima Y
    Am J Nephrol; 2001; 21(2):112-9. PubMed ID: 11359018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart is the Target Organ of Endogenous Cardiac Natriuretic Peptides.
    Tsutamoto T; Sakai H; Yamamoto T; Nakagawa Y
    Int Heart J; 2020 Jan; 61(1):77-82. PubMed ID: 31956150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Regulation of ANP and BNP in Acute Decompensated Heart Failure: Deficiency of ANP.
    Reginauld SH; Cannone V; Iyer S; Scott C; Bailey K; Schaefer J; Chen Y; Sangaralingham SJ; Burnett JC
    JACC Heart Fail; 2019 Oct; 7(10):891-898. PubMed ID: 31521687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man.
    Hunt PJ; Espiner EA; Nicholls MG; Richards AM; Yandle TG
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3871-6. PubMed ID: 8923831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasodilatory effects of B-type natriuretic peptide are impaired in patients with chronic heart failure.
    Nakamura M; Arakawa N; Yoshida H; Makita S; Niinuma H; Hiramori K
    Am Heart J; 1998 Mar; 135(3):414-20. PubMed ID: 9506326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous nitric oxide production and atrial natriuretic peptide biological activity in infants undergoing cardiac operations.
    Seghaye MC; Duchateau J; Bruniaux J; Demontoux S; Détruit H; Bosson C; Lecronier G; Mokhfi E; Serraf A; Planché C
    Crit Care Med; 1997 Jun; 25(6):1063-70. PubMed ID: 9201062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with darusentan over 21 days improved cGMP generation in patients with chronic heart failure.
    Philipp S; Monti J; Pagel I; Langenickel T; Notter T; Ruschitzka F; Lüscher T; Dietz R; Willenbrock R
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():249S-253S. PubMed ID: 12193097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of natriuretic peptides in cGMP production in fetal cardiac bypass.
    Heeb EA; Baker RS; Lam C; Basu M; Lubbers W; Duffy JY; Eghtesady P
    Ann Thorac Surg; 2009 Mar; 87(3):841-7. PubMed ID: 19231402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of the brain natriuretic peptide to atrial natriuretic peptide ratio in determining the severity of mitral regurgitation.
    Shimamoto K; Kusumoto M; Sakai R; Watanabe H; Ihara S; Koike N; Kawana M
    Can J Cardiol; 2007 Mar; 23(4):295-300. PubMed ID: 17380223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between plasma levels of atrial natriuretic peptide and cyclic guanosine monophosphate in patients with heart diseases.
    Nakaoka H; Imataka K; Kitahara Y; Fujii J; Ishibashi M; Yamaji T
    Jpn Circ J; 1988 Jan; 52(1):30-4. PubMed ID: 2834571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncoupling of atrial natriuretic peptide extraction and cyclic guanosine monophosphate production in the pulmonary circulation in patients with severe heart failure.
    Tsutamoto T; Kanamori T; Wada A; Kinoshita M
    J Am Coll Cardiol; 1992 Sep; 20(3):541-6. PubMed ID: 1324959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of endogenous atrial natriuretic peptide in DOCA-salt hypertensive rats. Effects of a novel nonpeptide antagonist for atrial natriuretic peptide receptor.
    Hirata Y; Matsuoka H; Suzuki E; Hayakawa H; Sugimoto T; Matsuda Y; Morishita Y; Kangawa K; Minamino N; Matsuo H
    Circulation; 1993 Feb; 87(2):554-61. PubMed ID: 8381060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction.
    Tsutamoto T; Wada A; Maeda K; Hisanaga T; Maeda Y; Fukai D; Ohnishi M; Sugimoto Y; Kinoshita M
    Circulation; 1997 Jul; 96(2):509-16. PubMed ID: 9244219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limitations of compensation by endogenous atrial natriuretic peptide in heart failure.
    Tsutamoto T; Kanamori T; Wada A; Miyauchi N; Murata T; Kinoshita M
    Jpn Circ J; 1992 May; 56(5):489-93. PubMed ID: 1318429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial and brain natriuretic peptide and endothelin-1 concentration in patients with idiopathic arterial hypertension: the dependence on the selected morphological parameters.
    Irzmański R; Banach M; Piechota M; Kowalski J; Barylski M; Cierniewski C; Pawlicki L
    Clin Exp Hypertens; 2007 Apr; 29(3):149-64. PubMed ID: 17497342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Equimolar doses of atrial and brain natriuretic peptides and urodilatin have differential renal actions in overt experimental heart failure.
    Chen HH; Cataliotti A; Schirger JA; Martin FL; Burnett JC
    Am J Physiol Regul Integr Comp Physiol; 2005 May; 288(5):R1093-7. PubMed ID: 15627648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
    Yasue H; Yoshimura M; Sumida H; Kikuta K; Kugiyama K; Jougasaki M; Ogawa H; Okumura K; Mukoyama M; Nakao K
    Circulation; 1994 Jul; 90(1):195-203. PubMed ID: 8025996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.